Products & Services

• • Drug
  • Research
• • Development

Web Result

Parfet named to Tolera Board

Home About Us Product Pipeline News Contact Us PRESS RELEASE Tolera Therapeutics Announces Election of Donald R. Parfet to the Board of Directors Tuesday, May 1st, 2007: Tolera Therapeutics, Inc., announced the election of Donald Parfet to its Board of Directors. Don is Managing Director of Apjohn Group, LLC, a business development firm comprised of experienced business and pharmaceutical professi...

http://www.tolera.com/news/PR052007DP.html

Product Pipeline

Home About Us Product Pipeline News Contact Us Product Pipeline Overview Transplantation Type 1 Diabetes Markets and Product Pipeline Overview Tolera plans to develop and commercialize therapies for the Short Course Immune Induction Therapy (SCIIT) markets; to address unmet medical needs with safer, targeted solutions. These markets include segments such as autoimmune disease and transplantation. ...

http://www.tolera.com/products.html

Tolera Raises $8 Million

Home About Us Product Pipeline News Contact Us PRESS RELEASE Tolera Therapeutics closes Series A financing, raises $8 million to begin antibody manufacturing and working with FDA on clinical trials. Monday, June 16, 2008- Tolera Therapeutics Inc., a newly formed biotechnology company focusing on the development of immunotherapeutics directed at the transplantation, oncology and autoimmune disease ...

http://www.tolera.com/news/PR062008SA.html

Tolera Therapeutics - Bringing Targeted and Safer Therapies to Market

Home About Us Product Pipeline News Contact Us Management Team Tolera has an experienced management team in place. A disciplined team which will generate value through aggressive new product commercialization, build-out of a valuable product pipeline, development of a solid intellectual property portfolio, and collaboration with world-class strategic partners. John J. Puisis Co-Founder, President ...

http://www.tolera.com/management_team.html

Tolera Therapeutics - Bringing Targeted and Safer Therapies to Market

Home About Us Product Pipeline News Contact Us About Us Overview Management Team Transplantation Medical Advisors Immunological Tolerance and Technology Advisors Board of Directors Partners Board of Directors Suzette Dutch, is Managing Partner of Triathlon Medical Ventures. She has 20 years venture investing and 10 years operating experience in pharmaceuticals, surgical devices and diagnostics. At...

http://www.tolera.com/board.html

Website Links: